2025. A Techno-Legal Study on Current IPR Scenario for Commercialization of Biosimilars in the USA. Journal of Intellectual Property Rights (JIPR). 30, 3 (Apr. 2025), 349–360. DOI:https://doi.org/10.56042/jipr.v30i3.8221.